Tirzepatide dosing schedule
tirzepatide dosage> Updated:
Calculate the Tirzepatide dose
The calculator is already set up for Tirzepatide — adjust the dose or diluent volume for your vial.
In short
Tirzepatide is given subcutaneously once weekly. The start is 2.5 mg; the dose is raised by 2.5 mg no more often than every 4 weeks, so full titration to the 15 mg maximum takes 20 weeks. In SURMOUNT-1 (NEJM, 2022), mean body-weight change over 72 weeks was -15.0% at 5 mg, -19.5% at 10 mg and -20.9% at 15 mg versus -3.1% on placebo.
Human dosing
Tirzepatide dosing is raised gradually in clinical trials, so the 2.5 mg titration steps in the table below reflect an escalation protocol, not an arbitrary dose choice.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start (weeks 1–4) | 2.5 mg weekly | Starting dose |
| Titration | 5 → 7.5 → 10 → 12.5 mg weekly | +2.5 mg every 4 weeks if needed |
| Maximum | 15 mg weekly | Maximum in this schedule |
Practical dosing and effect details
In the SURMOUNT-1 trial (Jastreboff and colleagues, New England Journal of Medicine, 2022), 2,539 adults with obesity received subcutaneous tirzepatide once weekly at 5, 10, or 15 mg, after a 20-week titration period, over 72 weeks.
Mean body weight change was -15.0% at 5 mg, -19.5% at 10 mg, and -20.9% at 15 mg, versus -3.1% with placebo (p<0.001 for each comparison). The result was clearly dose-dependent: a higher dose within the studied range corresponded to a larger average weight change. After titration ended, participants stayed on the same dose with no further increase through week 72, so the «Maximum» row in the table on this page marks a hold point, not a step to keep climbing past.
The trial's 20-week titration period matches exactly a +2.5 mg step every 4 weeks: five such steps from 2.5 to 15 mg add up to those 20 weeks, the same schedule shown in the table on this page. This is reference information from published studies, not a medical recommendation and not a guaranteed outcome for any individual.
Frequently asked questions
What is the starting dose of tirzepatide? 2.5 mg subcutaneously once weekly for the first 4 weeks. The dose is then raised in 2.5 mg steps: 5, 7.5, 10, 12.5 and up to the 15 mg maximum.
How fast can the dose be increased? No more often than every 4 weeks. Five steps from 2.5 to 15 mg add up to 20 weeks of titration – the same period used in SURMOUNT-1.
What is the maximum tirzepatide dose? 15 mg once weekly. In SURMOUNT-1, participants stayed on their dose after titration with no further increase through week 72; at 15 mg the mean body-weight change was -20.9%.
Does tirzepatide come in tablets? No. Tirzepatide exists only as a weekly subcutaneous injection; there is no tablet form of this molecule.
How many U-100 syringe units is a dose? It depends on the concentration of the reconstituted vial: units = dose (mg) divided by concentration (mg/mL) times 100. For example, at 10 mg/mL a 2.5 mg dose is 0.25 mL, i.e. 25 units.
How to reconstitute
An example reconstitution for convenient dosing. The exact ratios depend on your vial. For research reference only — not medical guidance.
- 1Add the diluentUse bacteriostatic water. Example: 2 ml into a 5 mg vial.Tirzepatide5 mg+ 2 mlDiluent
- 2Get the concentrationExample: 5 mg in 2 ml =Tirzepatide2.5 mg/ml(2,500 mcg/ml)
- 3Work out the volume per doseFor example, for a 2.5 mg dose:2.5 mg = 1 ml= 100 u. (U-100)
This is only an example calculation. You can use a different diluent volume — plug your own numbers into the calculator. Open calculator →
Research protocols
Tirzepatide: reference regimens
Tirzepatide is given as a subcutaneous injection once weekly.
More scientific background in the Tirzepatide monograph
Notes and safety
- • Tirzepatide is a research peptide. Human safety and efficacy data are limited.
- • The regimens shown are based on publications and research protocols, not clinical recommendations.
- • Individual reactions may vary. Published protocols typically start dosing at the lower end of the reported range.
- • Not recommended for use with chronic illness, pregnancy, or breastfeeding.
- • This information is for educational purposes and is not medical advice.
